Hera Biotech
© Hera Biotech

United States of America

Hera Biotech

  • 2025
  • Speaker
  • Venture

Hera Biotech features MetriDx™ and HeraFem®.  MetriDx™ is a non-surgical test for the definitive diagnosis and staging of endometriosis, and HeraFem® is a point-of-care cervical cancer diagnostic device that delivers real-time results.